Table 2:
Table of Validation Cohort
Summary | Median Age | Range Age | Number of Samples | Male:Female | Pan:Left:Proc (U) | Dur Med |
---|---|---|---|---|---|---|
Control | 44 | 24–68 | 6 | 5:1 | NA | NA |
Low Risk (Acute) | 40 | 20–66 | 17 | 6:11 | 2:6:9 | 3 |
Intermediate (Chronic) | 45 | 21–73 | 23 | 10:13 | 14:3:6 | 17 |
Field mucosa | 57 | 38–78 | 19 | 15:4 | 11:2:1 (3) | 11 |
UC-Dys | 63.5 | 43–73 | 10 | 6:4 | 5:1:2 (2) | 10 |
UC-Can | 54 | 26–67 | 16 | 14:2 | 12:0:2 (2) | 10 |